DEVELOPMENTS IN TREATMENT OF PARKINSONISM

被引：3

作者：

CALNE, DB ^{[1
]}

机构：

[1] NIH,BETHESDA,MD 20014

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1976年 / 295卷 / 25期

关键词：

D O I：

10.1056/NEJM197612162952511

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1433 / 1434

页数：2

共 10 条

[1] BROMOCRIPTINE IN PARKINSONISM [J].

CALNE, DB ;

TEYCHENNE, PF ;

CLAVERIA, LE ;

EASTMAN, R ;

GREENACRE, JK ;

PETRIE, A .

BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5942) :442-444

[2] TREATMENT OF PARKINSONS-DISEASE WITH APORPHINES - POSSIBLE ROLE OF GROWTH-HORMONE [J].

COTZIAS, GC ;

PAPAVASILIOU, PS ;

TOLOSA, ES ;

MENDEZ, JS ;

BELLMIDURA, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (11) :567-572

[3]

DUVOISIN RC, 1976, LANCET, V2, P204

[4] EFFECT OF CB-154 (2-BROMO-ALPHA-ERGOCRYPTINE) ON PARALYSIS AGITANS COMPARED WITH MADOPAR IN A DOUBLE-BLIND, CROSSOVER TRIAL [J].

GERLACH, J .

ACTA NEUROLOGICA SCANDINAVICA, 1976, 53 (03) :189-200

[5] STUDIES WITH BROMOCRIPTINE .1. ON-OFF PHENOMENA [J].

KARTZINEL, R ;

CALNE, DB .

NEUROLOGY, 1976, 26 (06) :508-510

[6]

KARTZINEL R, 1976, LANCET, V2, P272

[7] STUDIES ON ANTIPARKINSONIAN EFFICACY OF LERGOTRILE [J].

LIEBERMAN, A ;

MIYAMOTO, T ;

BATTISTA, AF ;

GOLDSTEIN, M .

NEUROLOGY, 1975, 25 (05) :459-462

[8] BROMOCRIPTINE TREATMENT IN PARKINSONS-DISEASE [J].

PARKES, JD ;

MARSDEN, CD ;

DONALDSON, I ;

GALEADEBONO, A ;

WALTERS, J ;

KENNEDY, G ;

ASSELMAN, P .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1976, 39 (02) :184-193

[9]

TEYCHENNE PF, 1975, LANCET, V2, P473

[10]

WASS JAH, 1976, LANCET, V2, P851

← 1 →